ARTES Biotechnology
To describe ARTES Biotechnology in a nutshell: We are globally working, well established and a reliable technology provider for recombinant protein production. We are experts in the field of developing microbial cell lines and processes for your target of choice: that can be a vaccine, a biopharmaceutical, a biosimilar and/or enzyme. We have also a broad spectrum of ready-to-transfer processes for enzymes, vaccines and biosimilars.
We value our partnership with you. Our highly experienced team is available for custom projects, offering the most efficient solution. We are experts in solving problems and setting up manufacturing processes.
All platform technologies (microbial cell line development and antigen presentation) ensure freedom-to-operate and are protected by patents and trade secrets. ARTES is available to negotiate exclusive license terms.
International registrations including US-FDA, EMA and NRC approvals; GRAS certifications and WHO recommendation are part of the track record achieved in our international collaborations. Large-scale manufacturing and full analytics in accordance with cGMP guidelines are warranted in collaboration with partners.